The market for artificial tendons and ligaments was valued at USD 18.8 millions in 2018. It is forecast to grow 11.3% during the forecast period. The market is driven by the increasing incidence of sports injuries. Sports injuries are often caused by improper equipment, bad training, improper practice, inadequate warm-up, stretching, or lack of conditioning. Sports injuries that are most commonly seen in athletes include groin pulls, hamstring strains, ACL tears, tennis elbow, hamstring strains, and groin pulls.
A large number of people don't know about safety precautions that can be used to prevent injuries from sports. According to statistics from the Parliament of England (A&E), there were 165,000 sports-related injuries in England's A&E departments in 2016.
Additionally, the increasing popularity of minimally-invasive surgeries and government initiatives to raise awareness about sports injuries will lead to an increase in synthetic tendon and ligament use for the knee, ankle and tendon reinforcement.
Allogeneic and autologous grafts can cause complications like tendon rupture, quadriceps weakness and loss of full extension. The risks involved in autograft and allograft procedures have led to the creation of synthetic materials for ligament reconstruction. The market players, as well as research organizations, are now focusing their R&D efforts to discover a new material that is immune-free, has high tensile strength, and resists abrasion.
Researchers are also developing new synthetic ligament grafts to integrate with native bone, stabilize the knee and encourage growth of new ligament tissue. In July 2017, Hokkaido University scientists developed a flexible, tough, fiber-reinforced, hydrogel biomaterial that is durable and can withstand everyday wear and tear. Researchers suggested that the material could be used to create artificial tendon or ligaments. This market is expected to continue its rapid growth thanks to increased R&D.
Due to the growing number of ACL injuries in athletes and other sportspeople, the knee injury segment will be a significant share over the forecast period. In the future, the segment will grow due to improvements in ACL reconstruction techniques that are more efficient.
Other applications include hip dislocations, elbow injuries, spinal injuries, and other injuries. This segment is expected to grow significantly due to an increase in total Femoral Tumor Resections and prosthetic Replacement Procedures owing their high success rate. This segment includes IntraSpine and NAJA, InternalBrace, Arthrex, LARS, Cousin Biotech and IntraSpine.
The segment will also be driven by a growing geriatric population. As we age, weak bones, soft connective tissue such as ligaments and tendon and cartilage wear and tear increase the risk of developing knee-related injuries. WHO predicts that the world's 85-year-old population will grow by 351% in the next 40 years. Meanwhile, the 65-year-old population will rise by 188% over the same period.
Hospitals and clinics dominated the global artificial ligaments market by end use in 2018. The segment is expected to continue its steady growth over the forecast period. The higher readmission rates and high volumes of patient turnaround can be attributed to the increased complications that result from surgery. Supportive infrastructure that facilitates successful surgeries will also increase the adoption of these grafts in hospitals and clinics.
The hospitals and clinics sector will continue to grow due to the increasing number of government initiatives to promote surgical facilities. This will improve healthcare effectiveness and deliver quick results. The segment's major share is due to the collaboration of key players and orthopedic clinics in raising awareness about sports injuries.
Due to an increase in ankle and shoulder-related surgeries performed at ASCs and attached outpatient units, the segment of ambulatory surgery centers will grow at a profitable rate over the forecast period. In the near future, there will be a rise in awareness about minimally invasive surgery.
Europe held a significant share of the global market in 2018, due to its growing product adoption and awareness about artificial grafts as a treatment for various sports injuries. The market will be fueled by the presence of major players in the region. The Corin Group distributes LARS ligaments to the U.K., while Xiros Ltd (U.K.), manufactures the Leeds Keio ligament and the PatellarTape System as well as Jewel ACL products (under brand name Neoligaments). These players are also focusing on expanding distribution networks in the area, which will increase product penetration.
France, Germany, and the U.K. were the top markets in Europe. They contributed more than 60% of the revenue in 2018. This is due to an increase in the number of anterior cruciate ligament ruptures (ACL) in Europe, which has been accompanied by increased participation in sport activities. According to a 2017 article in Health Economics Review, 30,000 ACL ruptures in Germany are repaired each year. This amounts to USD 129.61 millions in hospital costs.
Market growth in Asia Pacific is expected to be significant during the forecast period. This market is driven by significant research and development investments by global market leaders as well as growing awareness about artificial tendons, ligaments and ACL procedures. Australia and Japan are established markets in the region, while China and India are expected to experience high growth during the forecast period.
The current situation favors the use of autologous, allogenic tendons and ligaments for orthopedic surgery related to knee, ankle and shoulder. The LARS artificial ligament, which has been widely used in Canada and other European countries, isn't approved by the U.S. FDA. The upcoming product approvals, which will be supported by ongoing clinical trials, are expected to create a platform for North America's growth over the forecast period.
Mathys AG Bettlach, Xiros Ltd. (Neoligament), Corin Group and Corin Group collectively held more than 60.0% of 2018's market. These top players are now focusing on expanding their distribution channels and R&D facilities to expand their geographical footprint and production capacities, strengthening their market position. Corin, for example, established a new headquarters in the U.K. in June 2018. This strategic move is expected to boost the company's manufacturing capacity and distribution capabilities, further assisting its growth on both the local and global markets.
Cousin Biotech and BioMed are emerging players who focus on fundraising to support R&D and product commercialization. These companies participate in conferences to promote their products and increase their customer base. Orthomed was a participant in both the 2017 SFA Congress conference in Marseille and the GEM Congress in Paris, to show its 'LIGASTIC’ ligaments.
This report predicts revenue growth at the global, regional and country level and offers an analysis of industry trends in each sub-segment from 2014 to 2025. Grand View Research segmented the global market for artificial tendons and ligaments based on their application, end-use and location.
App Outlook (Revenue USD Million, 2014-2025)
Knee Injuries
Shoulder Injuries
Foot and Ankle Injuries
Other
End-use Outlook (Revenue USD Million, 2014-2025)
Hospitals and Clinics
Ambulatory Surgery Centers
Regional Outlook (Revenue USD Million, 2014-2025)
North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
b. The market for artificial tendons and ligaments was valued at USD 20.826 millions in 2019, and is forecast to grow to USD 23.09million in 2020.
What is the market growth for artificial tendons or ligaments?b. Global artificial tendons and ligaments markets are expected to expand at a compound annual rate of 11.3% between 2019-2025, to reach USD 39.564 million by 2025.
Which market segment had the largest share of artificial tendons or ligaments?b. With a 48.57% share in 2019, Europe was the dominant market for artificial tendons and ligaments. This can be attributed to increasing product adoption, high awareness about artificial ligaments and grafts, as well as the presence of key players.
What are the major players in the artificial tendons and/or ligaments market?b. Among the key players in the market for artificial tendons or ligaments are Corin Group, Xiros Ltd. (Neoligament), Mathys AG Bettlach.
What are the driving factors for the market for artificial tendons or ligaments?b. The market for artificial tendons and ligaments is growing due to the rising incidence of sports injuries, preference towards minimally invasive surgery, government initiatives that raise awareness about sports injuries and advances in surgical techniques.
Up Market Research published a new report titled “Artificial Tendons and Ligaments Market research report which is segmented by Application (Knee Injuries, Foot & Ankle Injuries, Shoulder Injuries), by End Use (ASCs, Hospitals & Clinics), By Players/Companies Xiros Ltd (Neoligament), Corin Group, Mathys AG Bettlach”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Artificial Tendons and Ligaments Market Research Report |
By Application | Knee Injuries, Foot & Ankle Injuries, Shoulder Injuries |
By End Use | ASCs, Hospitals & Clinics |
By Companies | Xiros Ltd (Neoligament), Corin Group, Mathys AG Bettlach |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 225 |
Number of Tables & Figures | 158 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Application (Knee Injuries, Foot & Ankle Injuries, Shoulder Injuries), by End Use (ASCs, Hospitals & Clinics).
Artificial Tendons and Ligaments Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Artificial Tendons and Ligaments Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Artificial Tendons and Ligaments Market Report:
Some other reports from this category!